Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. The Company has a platform for discovering proprietary compounds that work through a modulation of the NMDA receptor to enhance pathways involved with nerve cell communication.